# Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment

> **NCT02111434** · PHASE4 · COMPLETED · sponsor: **Gulhane School of Medicine** · enrollment: 150 (actual)

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** Testosterone

## Key facts

- **NCT ID:** NCT02111434
- **Lead sponsor:** Gulhane School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2014-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02111434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02111434, "Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02111434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*